Correlation Between Sutro Biopharma and Vaxcyte
Can any of the company-specific risk be diversified away by investing in both Sutro Biopharma and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sutro Biopharma and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sutro Biopharma and Vaxcyte, you can compare the effects of market volatilities on Sutro Biopharma and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sutro Biopharma with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sutro Biopharma and Vaxcyte.
Diversification Opportunities for Sutro Biopharma and Vaxcyte
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Sutro and Vaxcyte is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Sutro Biopharma and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and Sutro Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sutro Biopharma are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of Sutro Biopharma i.e., Sutro Biopharma and Vaxcyte go up and down completely randomly.
Pair Corralation between Sutro Biopharma and Vaxcyte
Given the investment horizon of 90 days Sutro Biopharma is expected to under-perform the Vaxcyte. In addition to that, Sutro Biopharma is 1.67 times more volatile than Vaxcyte. It trades about -0.02 of its total potential returns per unit of risk. Vaxcyte is currently generating about 0.05 per unit of volatility. If you would invest 7,142 in Vaxcyte on August 28, 2024 and sell it today you would earn a total of 2,028 from holding Vaxcyte or generate 28.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sutro Biopharma vs. Vaxcyte
Performance |
| Timeline |
| Sutro Biopharma |
| Vaxcyte |
Sutro Biopharma and Vaxcyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sutro Biopharma and Vaxcyte
The main advantage of trading using opposite Sutro Biopharma and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sutro Biopharma position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.| Sutro Biopharma vs. Vaxcyte | Sutro Biopharma vs. Larimar Therapeutics | Sutro Biopharma vs. Syndax Pharmaceuticals | Sutro Biopharma vs. Merus BV |
| Vaxcyte vs. Larimar Therapeutics | Vaxcyte vs. Syndax Pharmaceuticals | Vaxcyte vs. Merus BV | Vaxcyte vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |